For this we focused more specifically on the diseases that showed the highest degree of association with CEACAM6 based on the above literature profiling results (i.e., diseases mentioned in more than 20 articles, which are listed inTable 2), namely: leukemia, colorectal, pancreatic, lung, and breast cancers, as well as Inflammatory bowel disease. Here, CEACAM6 is linked to leukemia.